IP Library › Granted Patent US 11,207,248
Granted Patent B2
US 11,207,248 · App. 14/937,335 · Granted Dec 28, 2021

Personal care compositions with two benefit phases

Inventors: Karl Shiqing Wei (Mason, OH); Scott William Syfert (Fort Mitchell, KY); Shannon Dale Wagers (Liberty Township, OH); Brent William Mason (West Chester, OH)
Assignee: The Procter and Gamble Company
A61K8/04A61K8/20A61K8/31A61K8/466A61K8/60A61K8/73A61K8/8147A61K8/90A61K8/922A61Q19/00A61Q19/10A61K2800/412
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,207,248
App. No.
14/937,335
Granted
Dec 28, 2021
Kind
B2
Abstract

A personal care composition includes a structured cleansing phase and two separate benefit phases, wherein the first benefit phase containing a high viscosity benefit agent with an average particle size of about 50 μm to about 500 μm, wherein the second benefit phase comprises a low viscosity benefit agent with an average particle size of about 0.5 μm to about 10 μm.

Claims (17)

1. A personal care composition comprising:

a) a cleansing phase comprising:

i) from about 5.0% to about 15%, by weight of the composition, of sodium trideceth 2 sulfate;

ii) from about 1.0% to about 4%, by weight of the composition, of cocoamidopropyl betaine;

iii) from about 0.1 to about 1%, by weight of the composition, of cationic guar with a charge density of about 0.2 meq/g to about 2.0 meq/g;

iv) a structuring system comprising an associative polymer and a non-associative polymer; and

b) a first benefit phase comprising petrolatum, wherein the average particle size of the first benefit phase is from about 50 μm to about 500 μm and the petrolatum is not encapsulated; and

c) a second benefit phase comprising soy bean oil, wherein the average particle size of the second benefit phase is from about 0.5 μm to about 10 μm.

2. The personal care composition of claim 1 , wherein the first hydrophobic benefit phase is visually distinct from the second hydrophobic benefit phase.

3. The personal care composition of claim 1 , wherein the associative polymer comprises a polyacrylate, a hydrophobically-modified polysaccharide, a hydrophobically-modified urethane, or a mixture thereof.

4. The personal care composition of claim 1 , wherein the associative polymer comprises an alkyl acrylate polymer.

5. The personal care composition of claim 1 , wherein the associative polymer comprises an acrylate/C 10-C30 alkyl acrylate cross-polymer.

6. The personal care composition of claim 1 , wherein the structuring system further comprises an electrolyte.

7. The personal care composition of claim 6 , wherein the electrolyte is selected from the group consisting of sodium chloride, ammonium chloride, sodium sulfate, ammonium sulfate, and mixtures thereof.

8. The personal care composition of claim 1 , wherein the non-associative polymer is selected from the group consisting of polysaccharides, synthetic hydrocarbon polymers, and combinations thereof.

9. The personal care composition of claim 8 , wherein the polysaccharide comprises xanthan gum.

10. The personal care composition of claim 1 , wherein the benefit phase is free of surfactant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2016
From: WEI, KARL SHIQING; SYFERT, SCOTT WILLIAM; WAGERS, SHANNON DALE; MASON, BRENT WILLIAM
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 039219/0529 →
Continuity (2)
Provisional Application 62077679 · Nov 10, 2014
Related Publication 20160128913A1 · May 12, 2016